We are analyzing https://link.springer.com/article/10.1007/bf02574483.

Title:
Matrix metalloproteinases and their role in pancreatic cancer: A review of preclinical studies and clinical trials | Annals of Surgical Oncology
Description:
Matrix metalloproteinases (MMPs) have received much attention in recent years for their role in a variety of malignancies. Pancreatic cancer is no exception; MMP-2 and MMP-9 show high levels of expression in clinical and experimental models. Inhibition of MMPs has shown great promise with synthetic inhibitors, such as BB-94, as tumorostatic agents in preclinical models, particularly when these are combined with gemcitabine. These findings have led to several clinical trials using the MMP inhibitors Marimastat and BAY 12-9566. Herein, we discuss the roles of MMPs and their inhibition in pancreatic cancer.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

google, scholar, pubmed, cas, article, matrix, cancer, pancreatic, metalloproteinase, metalloproteinases, expression, mmp, res, tissue, inhibition, inhibitor, timp, inhibitors, biol, zervos, rosemurgy, human, gene, tumor, surg, collagenase, type, metastasis, bloomston, chem, shafii, oncol, marimastat, cells, clin, sci, med, activity, patients, privacy, cookies, content, role, clinical, access, kahari, cell, activation, cancerj, publish,

Topics {✒️}

month download article/chapter c-ets oncoprotein activates x-ray crystal structure furin-dependent intracellular activation full article pdf surgical oncology aims transin/stromelysin gene expression type iv collagenases human pancreatic cancer reduces tumor growth tumour growth privacy choices/manage cookies related subjects serum tumor markers human pancreatic adenocarcinomas unresectable pancreatic cancer rosemurgy ii md membrane type 1-mmp matrix metalloproteinase-2 activity cancer gene therapy human pancreatic carcinoma advanced pancreatic cancer map kinase cascades pancreatic cancer progression human stromelysin-3 zymogen pancreatic ductal adenocarcinomas phase ii trial matrisian lm zervos md & alexander matrix metalloproteinase inhibition article bloomston matrix metalloproteinase degradation pancreatic cancer invasion primary breast carcinomas resectable pancreatic carcinoma intact basement membrane control enzyme activity extracellular matrix proteins cell surface receptor surgical oncology 9 tgf-beta 1 inhibition european economic area shown great promise hill-harmon mb woessner jf jr fos binding sequence substrate analogue reveals healthy male volunteers k-ras mutations cell surface activation

Questions {❓}

The AP-1 site and MMP gene regulation: what is all the fuss about?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Matrix metalloproteinases and their role in pancreatic cancer: A review of preclinical studies and clinical trials
         description:Matrix metalloproteinases (MMPs) have received much attention in recent years for their role in a variety of malignancies. Pancreatic cancer is no exception; MMP-2 and MMP-9 show high levels of expression in clinical and experimental models. Inhibition of MMPs has shown great promise with synthetic inhibitors, such as BB-94, as tumorostatic agents in preclinical models, particularly when these are combined with gemcitabine. These findings have led to several clinical trials using the MMP inhibitors Marimastat and BAY 12-9566. Herein, we discuss the roles of MMPs and their inhibition in pancreatic cancer.
         datePublished:
         dateModified:
         pageStart:668
         pageEnd:674
         sameAs:https://doi.org/10.1007/BF02574483
         keywords:
            Pancreatic cancer
            Matrix metalloproteinase
            MMP
            TIMP
            Surgical Oncology
            Oncology
            Surgery
         image:
         isPartOf:
            name:Annals of Surgical Oncology
            issn:
               1534-4681
               1068-9265
            volumeNumber:9
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Mark Bloomston
               affiliation:
                     name:University of South Florida
                     address:
                        name:Department of Surgery, University of South Florida, Tampa
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Emmanuel E. Zervos
               affiliation:
                     name:University of South Florida
                     address:
                        name:Department of Surgery, University of South Florida, Tampa
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Alexander S. Rosemurgy
               affiliation:
                     name:University of South Florida
                     address:
                        name:Department of Surgery, University of South Florida, Tampa
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Matrix metalloproteinases and their role in pancreatic cancer: A review of preclinical studies and clinical trials
      description:Matrix metalloproteinases (MMPs) have received much attention in recent years for their role in a variety of malignancies. Pancreatic cancer is no exception; MMP-2 and MMP-9 show high levels of expression in clinical and experimental models. Inhibition of MMPs has shown great promise with synthetic inhibitors, such as BB-94, as tumorostatic agents in preclinical models, particularly when these are combined with gemcitabine. These findings have led to several clinical trials using the MMP inhibitors Marimastat and BAY 12-9566. Herein, we discuss the roles of MMPs and their inhibition in pancreatic cancer.
      datePublished:
      dateModified:
      pageStart:668
      pageEnd:674
      sameAs:https://doi.org/10.1007/BF02574483
      keywords:
         Pancreatic cancer
         Matrix metalloproteinase
         MMP
         TIMP
         Surgical Oncology
         Oncology
         Surgery
      image:
      isPartOf:
         name:Annals of Surgical Oncology
         issn:
            1534-4681
            1068-9265
         volumeNumber:9
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Mark Bloomston
            affiliation:
                  name:University of South Florida
                  address:
                     name:Department of Surgery, University of South Florida, Tampa
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Emmanuel E. Zervos
            affiliation:
                  name:University of South Florida
                  address:
                     name:Department of Surgery, University of South Florida, Tampa
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Alexander S. Rosemurgy
            affiliation:
                  name:University of South Florida
                  address:
                     name:Department of Surgery, University of South Florida, Tampa
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Annals of Surgical Oncology
      issn:
         1534-4681
         1068-9265
      volumeNumber:9
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of South Florida
      address:
         name:Department of Surgery, University of South Florida, Tampa
         type:PostalAddress
      name:University of South Florida
      address:
         name:Department of Surgery, University of South Florida, Tampa
         type:PostalAddress
      name:University of South Florida
      address:
         name:Department of Surgery, University of South Florida, Tampa
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Mark Bloomston
      affiliation:
            name:University of South Florida
            address:
               name:Department of Surgery, University of South Florida, Tampa
               type:PostalAddress
            type:Organization
      name:Emmanuel E. Zervos
      affiliation:
            name:University of South Florida
            address:
               name:Department of Surgery, University of South Florida, Tampa
               type:PostalAddress
            type:Organization
      name:Alexander S. Rosemurgy
      affiliation:
            name:University of South Florida
            address:
               name:Department of Surgery, University of South Florida, Tampa
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Surgery, University of South Florida, Tampa
      name:Department of Surgery, University of South Florida, Tampa
      name:Department of Surgery, University of South Florida, Tampa
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(204)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

3.96s.

LINK . SPRINGER . COM {}